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Overall, the possibility of sparing the bowel at the cost of 
extra dose to the bladder and vice versa was demonstrated. 
The estimated change in primary tumor control for high 
versus low dose regimen was less than 1% for early stage 
tumors and approximately 5% for late stage tumors. 
 
 
 
 
 
Conclusion: There is room in the optimization space for 
incorporation of patient outcome and toxicity preferences. 
This opens for SDM for anal cancer patients. The study is to 
be expanded, with results for a total of 22 patients to be 
presented at ESTRO 2016. 
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Purpose or Objective: To explore the ability of quantitative 
prostate T2-weighted (T2-w) and apparent diffusion 
coefficient maps (ADC) MRI using Haralick texture features: i) 
to differentiate prostate cancer (PC) from healthy tissues; ii) 
to be correlated with Gleason score; iii) to predict 
biochemical recurrence after external beam radiotherapy 
(RT) for prostate cancer. 
 
Material and Methods: Tumor and prostate zones were 
segmented on co-registered T2-w and ADC on two pre-
treatment 3.0T MRI from 83 patients with a median age 67 
years (range 50-82 years) and a median pre-treatment PSA of 
9.8 ng/ml (range 3.4-48.0 ng/ml). 9 (11%) tumors were 
localized in the transitional zone (TZ) and 74 (89%) in the 
peripheral zone (PZ). Tumors were clinically staged as 
follows: 13% of T1, 46% of T2 and 41% of T3. Gleason scores 
were as follows: 6 (27%), 7 (51%), 8 (20%) and 9 (2%). They 
were 2% of low-risk, 33% of intermediate-risk and 65% of 
high-risk tumors according to D’Amico risk group 
classification. Almost all patients received standard 
treatment consisting in IMRT (100%) with IGRT (94%) 
associated with hormonal therapy in 53% of the patients. 
After a median follow-up of 47 months (range 19-65 months), 
11 patients had biochemical recurrence. A total of 114 grey-
leveled features (first order, gradient-based and second 
order Haralick texture characteristics) and 4 geometrical 
features (maximal tumor diameter, maximal tumor 
perimeter, maximal tumor area and tumor volume) were 
extracted on normalized T2-w and ADC and were analyzed. 
Statistical analyses were performed using Wilcoxon signed-
rank test, Spearman’s correlation coefficient, Harrell’s C-
index, Kaplan-Meier curves and univariate Cox regression 
analysis. 
 
Results: i) 56 out of 57 T2-w and 46 out of 57 ADC grey-
leveled features were significantly different between tumor 
and prostate tissues in the PZ and 25 out of 57 T2-w and 37 
out of 57 ADC features in the TZ (p<0.05). ii) 5 T2-w features 
and 4 ADC features were significantly correlated with 
Gleason score, all were Haralick texture features. iii) T2-w 
features that significantly predicted (p<0.05) biochemical 
recurrence were: maximal tumor 
diameter/perimeter/area/volume, Kirsch gradient operator, 
normalized mean and standard deviation of signal intensity 
and 8 Haralick texture features (Difference Variance, 
Contrast, Inverse Difference Moment, Difference Entropy, 
Information Measure of Correlation, Sum Average, Sum 
Variance and Sum of Squares). Only normalized mean value 
on ADC was significantly predictive of biochemical 
recurrence. 
 
Conclusion: Quantitative analysis using Haralick texture 
characteristics on T2-w MRI are good features: i) to 
differentiate prostate cancer from healthy tissues, ii) for 
Gleason score assessment and iii) to predict biochemical 
recurrence after RT. Geometrical characteristics extracted 
from T2-w are also good predictors of biochemical recurrence 
after RT. 
 
PV-0474 
Comparison of DCE MRI and FMISO-PET kinetic parameters 
in head and neck cancer patients 
U. Simoncic
1University Hospital Tübingen, Section for Biomedical Physics 
- Department of Radiation Oncology, Tübingen, Germany 
1,2,3, S. Leibfarth1, S. Welz4, N. Schwenzer5, H. 
Schmidt5, D. Zips4, D. Thorwarth1 
2Jozef Stefan Institute, Medical Physics program, Ljubljana, 
Slovenia 
3University o Ljubljana, Faculty for Mathematics and Physics, 
Ljubljana, Slovenia 
4University Hospital Tübingen, Department of Radiation 
Oncology, Tübingen, Germany 
5University Hospital Tübingen, Department of Diagnostic and 
Interventional Radiology, Tübingen, Germany 
 
Purpose or Objective: Tumour hypoxia is associated with 
poor response to radiotherapy. Comprehensive hypoxia 
assessment through [18F]-fluoromisonidazole (FMISO) PET 
imaging requires quantitative techniques, such as dynamic 
acquisition. However, dynamic FMISO PET protocols might be 
simplified by using DCE-MRI imaging in addition to static 
FMISO-PET. The aim of this work was to compare FMISO and 
DCE-MRI kinetic parameters by means of correlation analysis. 
 
Material and Methods: This study was done on N=6 head and 
neck cancer patients, who were imaged dynamically with 
FMISO-PET and DCE-MRI on the same day. Images were 
registered and analyzed for kinetics on a voxel basis. FMISO-
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PET images were analyzed with a two-tissue compartment 
three-rate constant model with an additional vasculature 
compartment. Consequently, the model had the following 
parameters: K1 – FMISO transport rate to the tissue, k2 – 
FMISO backflow parameter, k3 – rate of FMISO binding in the 
cells, and Vb – vasculature fraction in the tissue. DCE-MRI 
images were analyzed with the extended Tofts model with 
the following parameters: Ktrans – contrast agent transport 
rate to the tissue, ve – relative volume of the tissue, and vp – 
vasculature fraction in the tissue. Voxel-wise Pearson 
correlation coefficients were evaluated on pairs of 
parametric images for each patient over the tumour volume 
including lymph nodes and tumour bed, if present. FMISO 
kinetic parameters were modelled with multivariate linear 
models of DCE-MRI parameters. The relative likelihood of the 
models was evaluated using the Akaike information criterion. 
 
Results: Correlations between FMISO and DCE-MRI kinetic 
parameters, median over all the patients, varied across the 
parameter pairs from -0.12 to 0.71, with the highest 
correlation coefficient of 0.71 for Vb-vp pair, while K1-Ktrans 
correlation was 0.46. Correlations between FMISO and DCE-
MRI kinetic parameters varied also across the patients. 
Among various multivariate models for FMISO parameters, 
those with more DCE-MRI parameters were more likely. Table 
1 shows the correlation matrix for FMISO and DCE-MRI kinetic 
parameters with the median over all the patients in the 
lower-left and minimum/maximum in the upper-right 
triangle.  
 
 
 
Figure 1 shows K1 and Ktrans parametric images for the case 
with low K1-Ktrans correlation. Additional DCE-MRI kinetic 
analysis for this case, using the tissue homogeneity model 
revealed that tumour and tumour bed had different Ktrans 
because of considerably different permeability surface area 
product. 
 
 
 
Conclusion: Vasculature fractions from DCE-MRI and FMISO-
PET are interchangeable up to a scaling factor. Transport 
rates from DCE-MRI and FMISO-PET can be different; FMISO 
K1 measures blood flow, whereas the DCE-MRI Ktrans can be 
notably affected by the blood vessel permeability. 
Information from any single FMISO kinetic parameter is 
spread over multiple DCE-MRI parameters. 
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Purpose or Objective: Despite post-operative radiotherapy 
(RT) of glioblastoma (GBM), local tumor re-growths occur in 
irradiated areas and are responsible for poor outcome. 
Identification of sites with high probability of recurrence is a 
promising way to define new target volumes for dose 
escalation in RT treatments. This study aims at assessing the 
value of multi-parametric magnetic resonance (mp-MR) data 
acquired before RT treatment in the identification of regions 
at risk of relapse. 
 
Material and Methods: Ten newly diagnosed GBM patients 
included in a clinical trial, treated in the reference arm of 60 
Gy plus TMZ, underwent magnetic resonance imaging (MRI) 
and MR spectroscopy (MRSI) before RT treatment and every 2 
months until relapse. The site of relapse was considered as 
the new appearing contrast-enhancing (CE) areas on T1-
weighted images after gadolinium injection (T1-Gd). Using a 
set of mp-MR data acquired before RT treatment as input, a 
supervised learning system based on support vector machines 
(SVM) was trained to generate a probability map of CE 
appearance of GBM. More specifically, T1-Gd and FLAIR 
image intensities, Choline-over-NAA, Choline-over-Creatine 
and Lac-over-NAA metabolite ratios, and metabolite heights 
were used. The resolution of the MRI images was lowered to 
the one of the MRSI grid by averaging MRI pixel intensities 
within each MRSI voxel (400 MRSI voxels were considered for 
each subject). The region of CE was manually contoured on 
both the pre-RT and post-RT T1-Gd images by experienced 
medical staff. All voxels that enhanced at the pre-RT exam 
were excluded from further consideration. The learning 
system was trained and tested using leave-one-out-cross-
validation (LOOCV) with all the patients. A grid-search 
strategy was employed for parameter optimization. 
 
Results: For comparison purposes, generated probability 
maps were thresholded with a value of 0.5. Thus, only voxels 
with values higher than 0.5 on the probability map were 
considered as relapse. The sensitivity and specificity of the 
proposed system were 0.80 (±0.19) and 0.87 (±0.09), 
respectively. For our data, standard Choline-to-NAA index 
(CNI) achieved a sensitivity of 0.62 (±0.25) and a specificity 
of 0.63 (±0.13) (an optimal CNI threshold was derived for all 
the patients). The receiver operating characteristic (ROC) 
curve also shows that the presented approach outperforms 
CNI (Fig 1.). In addition, the SVM-based results had lower 
variation across patients than CNI. An example of a 
probability map generated by the proposed approach is 
shown in Fig.2. Relapse areas predicted by the learning 
scheme are in high accordance with the manually contoured 
regions. 
